Cell-based functional screening of modified betulins, abietanes and resin acids as lead compounds for anti-cancer drugs (BARC)

Matthias Nees, Raisa Haavikko, Vania Moreira, Sami Alakurtti, Jari Yli-Kauhaluoma, Heiko Rischer, Enkhee Purev, Johannes Virtanen, Kirsi-Marja Oksman-Caldentey

Research output: Chapter in Book/Report/Conference proceedingConference abstract in proceedingsScientific

Original languageEnglish
Title of host publicationTERPNET 2013
Subtitle of host publicationBook of Abstracts
PublisherAristotle University of Thessaloniki
Pages88
Number of pages1
Publication statusPublished - 2013
MoE publication typeNot Eligible
Event11th International Meeting on Biosynthesis, Function and Biotechnology of Isoprenoids in Terrestial and Marine Organisms, TERPNET 2013 - Crete, Greece
Duration: 1 Jun 20135 Jun 2013

Conference

Conference11th International Meeting on Biosynthesis, Function and Biotechnology of Isoprenoids in Terrestial and Marine Organisms, TERPNET 2013
CountryGreece
CityCrete
Period1/06/135/06/13
OtherA joint Meeting of TERPNET2013, Cost Action “Plant Engine”, Cost Action “QualityFruit”, “EU-SmartCell”.

Cite this

Nees, M., Haavikko, R., Moreira, V., Alakurtti, S., Yli-Kauhaluoma, J., Rischer, H., Purev, E., Virtanen, J., & Oksman-Caldentey, K-M. (2013). Cell-based functional screening of modified betulins, abietanes and resin acids as lead compounds for anti-cancer drugs (BARC). In TERPNET 2013: Book of Abstracts (pp. 88). [O53] Aristotle University of Thessaloniki.